UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 409

Sortiert nach

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Leukemia, 2020-04, Vol.34 (4), p.966-984

2020

Link zum Volltext

Verfügbarkeit prüfen

Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors

Leukemia, 2012-05, Vol.26 (5), p.1140-1143

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel approaches to treating advanced systemic mastocytosis

Clinical pharmacology: advances and applications, 2019-01, Vol.11, p.77-92

2019

Link zum Volltext

Verfügbarkeit prüfen

Age-related mutations and chronic myelomonocytic leukemia

Leukemia, 2016-04, Vol.30 (4), p.906-913

2016

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

The New England journal of medicine, 2013-11, Vol.369 (19), p.1783-1796

2013

Link zum Volltext

Verfügbarkeit prüfen

Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib

Leukemia, 2007-03, Vol.21 (3), p.489-493

2007

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib

Leukemia, 2017-12, Vol.31 (12), p.2844-2847

2017

Link zum Volltext

Verfügbarkeit prüfen

A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Leukemia, 2016-07, Vol.30 (7), p.1493-1501

2016

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

Leukemia, 2003-12, Vol.17 (12), p.2392-2400

2003

Link zum Volltext

Verfügbarkeit prüfen

Novel pyrrolo- 1 ,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo

British journal of cancer, 2010-05, Vol.102 (10), p.1474-1482

2010

Link zum Volltext

Verfügbarkeit prüfen

Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia

Leukemia, 2008-06, Vol.22 (6), p.1184-1190

2008

Link zum Volltext

Verfügbarkeit prüfen

The function of the pleckstrin homology domain in BCR-ABL-mediated leukemogenesis

Leukemia, 2010-01, Vol.24 (1), p.226-229

2010

Link zum Volltext

Verfügbarkeit prüfen

Detection of ABL kinase domain mutations with denaturing high-performance liquid chromatography

Leukemia, 2004-04, Vol.18 (4), p.864-871

2004

Link zum Volltext

Verfügbarkeit prüfen

An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia

Leukemia, 2008-12, Vol.22 (12), p.2269-2272

2008

Link zum Volltext

Verfügbarkeit prüfen

Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1

Leukemia, 2015-09, Vol.29 (9), p.1939-1942

2015

Link zum Volltext

Verfügbarkeit prüfen

Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells

Leukemia, 2005-11, Vol.19 (11), p.1896-1904

2005

Link zum Volltext

Verfügbarkeit prüfen

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

Leukemia, 2015-12, Vol.29 (12), p.2328-2337

2015

Link zum Volltext

Verfügbarkeit prüfen

High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML)

Leukemia, 2002, Vol.16 (1), p.22-29

2002

Link zum Volltext

Verfügbarkeit prüfen

Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells

Leukemia, 2008-07, Vol.22 (7), p.1354-1360

2008

Link zum Volltext

Verfügbarkeit prüfen

Extreme mutational selectivity of axitinib limits its potential use as a targeted therapeutic for BCR-ABL1-positive leukemia

Leukemia, 2016-06, Vol.30 (6), p.1418-1421

2016

Link zum Volltext

Verfügbarkeit prüfen

A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia

Leukemia, 2015-08, Vol.29 (8), p.1668-1675

2015

Link zum Volltext

Verfügbarkeit prüfen

The Tyrosine Kinase Inhibitor CGP57148B Selectively Inhibits the Growth of BCR-ABL–Positive Cells

Blood, 1997-11, Vol.90 (9), p.3691-3698

1997

Link zum Volltext

Verfügbarkeit prüfen

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

Leukemia, 2017-05, Vol.31 (5), p.1253-1254

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 409

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(375)
Mit Volltextzugriff
(385)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(209)
Life Sciences & Biomedicine
(188)
Humans
(174)
Hematology
(103)
Biological And Medical Sciences
(80)
Oncology
(78)
Medical Sciences
(72)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(64)
Female
(61)
Male
(60)
Animals
(57)
Adult
(52)
Imatinib Mesylate
(52)
Hematologic And Hematopoietic Diseases
(49)
Middle Aged
(49)
Aged
(47)
Benzamides
(47)
Chronic Myeloid Leukemia
(47)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(45)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors

Novel approaches to treating advanced systemic mastocytosis

Age-related mutations and chronic myelomonocytic leukemia

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib

Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib

A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

Novel pyrrolo- 1 ,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo

Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia

The function of the pleckstrin homology domain in BCR-ABL-mediated leukemogenesis

Detection of ABL kinase domain mutations with denaturing high-performance liquid chromatography

An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia

Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1

Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells

HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML)

Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells

Extreme mutational selectivity of axitinib limits its potential use as a targeted therapeutic for BCR-ABL1-positive leukemia

A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia

The Tyrosine Kinase Inhibitor CGP57148B Selectively Inhibits the Growth of BCR-ABL–Positive Cells

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

Suchergebnisse filtern